In support of improving patient care, this activity has been planned and implemented by CineMed and LER Expo. Cine-Med is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
CineMed designates this live activity for a maximum of 15.25 AMA PRA Category 1 Credit(s)™.
Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity provides 15.25 contact hours for nurses.
This activity has been planned and implemented in accordance with the standards and requirements for approval of providers of continuing education in podiatric medicine through a joint provider agreement between Cine-Med and LER Expo. Cine-Med is approved by the Council on Podiatric Medical Education as a provider of continuing education in podiatric medicine. Cine-Med has approved this activity for a maximum of 15.25 continuing education contact hours.
All other healthcare professionals will receive a Certificate of Participation. For information on the applicability and acceptance of Certificates of Participation for activities designated for AMA PRA Category 1 Credits™, consult your professional licensing board.
July 19, 2024 08:45 amPeter Gloviczki, MD, John Chuback, MD, and Richard Dubin
July 19, 2024 09:00 amModerators: Peter Gloviczki, MD, PhD and Ruth Bush, MD, JD, MPH
9:00 – 9:15 Pathophysiology and the updated CEAP classification of chronic venous disorders
Joseph Raffetto, MD
9:15 – 9:30 CLEF – Congestive lower extremity failure - a new paradigm of chronic venous insufficiency
John Chuback, MD
9:30 – 9:45 Evaluation of chronic venous disease with Duplex scan: best technique and correct interpretation
Nicos Labropoulos, PhD
9:45 – 10:00 Evaluation of patients with venous ulcers
Ruth Bush, MD, JD, MPH
10:00 – 10:30 Panel Discussion
July 19, 2024 10:30 amKeetha Hanlin RN, LME
Asclera and ScleroSafe are transforming patient experiences. Discover how innovative, modern vein procedures provide a higher level of patient care and satisfaction!
July 19, 2024 10:45 amModerators: Peter Gloviczki, MD, PhD and Julianne Stoughton, MD
10:45 – 11:00 Endovenous laser ablation of the great saphenous vein: technique and results
Jose Almeida, MD
11:00 – 11:15 Radiofrequency ablation of the great saphenous vein: technique and results
Misaki Kiguchi, MD
11:15 – 11:30 Endovenous treatment of the small saphenous vein: which technique is the best and how can we avoid nerve injury?
Julianne Stoughton, MD
11:30 – 11:45 Treatment of the incompetent anterior saphenous vein: why, when, and how?
Mark Meissner, MD
11:45 – 12:15 PM Panel discussion
July 19, 2024 12:15 pmJohn Chuback, MD
July 19, 2024 12:30 pmNeal M. Lonky MD, MPH and John Chuback MD
Learning Objectives
After the presentation the attendee will:
July 19, 2024 12:45 pmModerator: Peter Gloviczki, MD, PhD and Peter F. Lawrence, MD
12:45 – 1:00 PM Cyanoacrylate ablation of the great saphenous vein: benefits, drawbacks, results
Jose Almeida, MD
1:00 – 1:15 PM Treatment of the great saphenous vein with Polidocanol Endovenous Microfoam
Peter F. Lawrence, MD
1:15 – 1:30 PM MOCA, ultrasonic ablation and other emerging technologies for saphenous ablations
Steven Elias, MD
1:30 – 1:45 PM Treatment of the incompetent great saphenous vein below the knee: pitfalls and solutions
Manju Kalra, MBBS
1:45 – 2:15 PM Panel discussion
July 19, 2024 02:15 pmKathleen Gibson, MD
July 19, 2024 02:30 pmModerators: Peter Gloviczki, MD, PhD and Kathleen Gibson, MD
2:30 – 2:42 PM Liquid sclerotherapy vs laser treatment for telangiectasias and reticular veins
Kathleen Ozsvath, MD
2:42 – 2:54 PM Polidocanol Endovenous Microfoam for treatment of varicose vein
Kathleen Gibson, MD
2:54 – 3:06 PM Physician Compounded Foam and ultrasound guidance for treatment of telangiectasias and varicose veins
Kathleen Ozsvath. MD
3:06 – 3:18 PM New classification, terminology, and treatment of Ablation Related Thrombus Extension (ARTE)
Peter F. Lawrence, MD
3:18 – 3:30 PM Thrombosis prophylaxis for venous interventions: SVS/AVF/AVLS Guidelines
Andrea Obi, MD
3:30 – 4:00 PM Panel discussion
July 19, 2024 04:00 pm4:00 – 4:15 PM Patient Centric Solutions for Compression and Non-Bandage Venous Leg Ulcer Care
Vikram Ravikumar, COO
July 19, 2024 04:15 pmModerators: Peter Gloviczki, MD, PhD and Mark Melin, MD
4:15 – 4:27 PM The current state of local treatment of venous ulcers
Mark Melin, MD
4:27 – 4:39 PM Optimal management of biofilms in chronic wounds to improve outcome
Matthew Regulski, DPM
4:39 – 4:51 PM Effective and durable healing of difficult venous leg ulcers
Matthew G. Garoufalis, DPM
4:51 – 5:03 PM Venous insufficiency and the diabetic foot: a complicated relationship
Windy Cole, DPM, CWSP
5:03 – 5:15 PM The strategy of treatment of venous insufficiency in patients with venous ulcers
Manju Kalra, MBBS
5:15 - 5:30 PM Panel discussion
July 20, 2024 09:00 amModerators: Peter Gloviczki, MD, PhD and John Chuback, MD
9:00 – 9:15 Glycocalyx and new concepts on the pathophysiology of lymphedema and phlebolymphedema
Mark Melin, MD
9:15 – 9:30 Evaluation of patients with the swollen leg
Ruth Bush, MD, JD, MPH
9:30 – 9:45 Compression therapy for varicose veins and phlebo-lymphedema
Andrea Obi, MD
9:45 – 10:00 Drug therapy for lymphedema and phlebo-lymphedema
Monika L. Gloviczki, MDS, PhD
10:00 – 10:30 Panel Discussion
July 20, 2024 10:30 amKelli Lomas Roberts M.S.
July 20, 2024 10:45 amModerators: Peter Gloviczki, MD, PhD and Monika Gloviczki, MD, PhD
10:45 – 11:00 Classification and evaluation of patients with lymphedema
Peter Gloviczki, MD, PhD
11:00– 11:15 Long-term management strategies for lymphedema: elevation, exercise, compression
Thomas Maldonado, MD
11:15 – 11:30 Physical therapy for management of lower extremity lymphedema - it’s not manual lymphatic drainage
James McGuire, DPM, PT
11:30 – 11:45 The role of manual lymphatic drainage and surgery for lymphedema
Thomas Maldonado, MD
11:45 – 12:00 Diagnosis and evaluation of patients with lipedema
Emily Iker, MD
12:00 – 12:30 PM Panel discussion
July 20, 2024 12:30 pmJuly 20, 2024 12:45 pmModerators: Peter Gloviczki, MD, PhD and Joseph Raffetto, MD
12:45 -1:00 PM Contemporary management of lipedema
Emily Iker, MD
1:00 – 1:15 PM Outcome assessment of treatments for varicose veins and chronic venous insufficiency
Joseph Raffetto, MD
1:15 – 1:30 PM Standards of office-based laboratories and accredited vein centers
John Chuback, MD
1:30 – 1:45 PM SVS/AVF/AVLS Guidelines on the management of patients with varicose veins
Peter Gloviczki, MD, PhD
1:45 – 2:15 Panel discussion
July 20, 2024 02:15 pmJohn Chuback, MD
July 20, 2024 02:30 pmModerators: Peter Gloviczki, MD, PhD and Arjun Jayaraj, MD
2:30 – 2:45 PM Management of iliofemoral venous obstruction
Arjun Jayaraj, MD
2:45 - 3:00 PM Complications of iliac vein stenting: pitfalls, bailouts
Arjun Jayaraj MD
3:00 – 3:15 PM Interruption of perforating veins for prevention and treatment of venous ulcers
Misaki Kiguchi, MD
3:15 – 3:30 PM Veno-active drugs for treatment of patients with post-thrombotic syndrome
Monika L. Gloviczki, MD, PhD
3:30 – 4:00 PM Panel Discussion
July 20, 2024 04:00 pmModerators: Peter Gloviczki, MD, PhD, and Mark Meissner, MD
4:00 – 4:15 PM Clinical presentation and new clinical classification of patients with pelvic venous disorders
Mark Meissner MD
4:15 – 4:30 PM Evaluation of patients with pelvic pain and pelvic venous disorders
John White, MD
4:30 – 4:45 PM Management of perineal and vulvar varicosity
Kathleen Gibson, MD
4:45 – 5:00 PM Interventions for treatment of pelvic venous disorders
John White, MD
5:00 – 5:15 PM Treatment of varicose veins of pelvic origin
Julianne Stoughton, MD
5:15 – 5:45 PM Panel discussion
Peter Gloviczki, MD, PhD, FACS, is the Roberts Emeritus Professor of Surgery, previous Chair, Division of Vascular and Endovascular Surgery, at Mayo Clinic, Rochester, MN (2000-2010), recent Editor-in-Chief, Journal of Vascular Surgery (2016-2022). He received his Medical Degree at Semmelweis University with distinction (Sub Auspiciis Rei Publicae Popularis), trained in Budapest, in Paris, and at Mayo Clinic. Joined the staff of Mayo Clinic in 1987. His clinical practice included arterial, venous and lymphatic surgery. He is an expert in aortic, carotid and PAD reconstructions, in venous reconstructions, vascular malformations, lymphatic and chylous disorders. At Mayo Clinic he performed over 10,000 operations. He is Past President of the Society for Vascular Surgery, American Venous Forum, International Union of Angiology, World Federation of Vascular Societies, Society for Clinical Vascular Surgery, Midwest Vascular Surgery Society, Frank J. Veith International Society, among others. He is a member of the American Surgical Association, Distinguished Fellow of SVS, AVF, Honorary Member of 20 societies. Has 510 peer-reviewed publications, wrote over 250 book-chapters, edited eight textbooks, four Editions of the Handbook of Venous and Lymphatic Disorders, translated to Chinese and Polish. He was Associate Editor of Rutherford’s Vascular Surgery, 5th,6th,7th and 8th Editions. He has given >750 presentations and has 26,373 citations (h-index: 93, Scopus). The University of Washington, Seattle, established the Peter Gloviczki Professorship in Venous and Lymphatic Disorders. His Alma Mater awarded him the “Doctor Honoris Causa” degree and the “Semmelweis “Budapest” Award. He serves on the Board of Trustees of the Semmelweis University. Dr Gloviczki received the Officer’s Cross of the Order of Merit of Hungary. In 2023, he received an Honorary Doctorate Degree (PhD) in cardiovascular translational medicine from the 800-year-old University of Padua, Italy. His biography “Magic and Medicine” was recently published by Semmelweis University. Dr Gloviczki lives with his wife, Monika Gloviczki, MD, PhD, in Scottsdale, Arizona.
Chief Medical Officer, Chuback Vein Center, Paramus, New Jersey
Associate Professor of Surgery, Harvard Medical School; Chief, Section of Vascular Surgery, VA Boston Healthcare System; Brigham and Women’s Hospital, West Roxbury, Massachusetts
Professor of Surgery, Director, Vascular laboratory, University Hospital, Stony Brook, NY
Professor of Vascular Surgery and Associate Dean for Educational Affairs, John Sealy School of Medicine, The University of Texas Medical Branch, Galveston, TX
Voluntary Professor of Surgery, University of Miami Miller School of Medicine Founder, Miami Vein, Miami, FL
Associate Professor, Surgery; Program Director, Vascular Surgery Director, MedStar Vein Health Centers, MedStar Washington Hospital Center, Washington, DC
Assistant Professor, Harvard Medical School; Vascular Surgeon, Massachusetts General Hospital, Boston, Massachusetts
Professor of Surgery, Emeritus; David Geffen School of Medicine, Chief of Vascular and Endovascular Surgery, Emeritus; Gonda Vascular Center, University of California, Los Angeles, CA
Director, Center for Vein Disease, Englewood Hospital and Medical Center, Englewood, New Jersey
Professor of Surgery and Consultant, Division of Vascular and Endovascular Surgery, Mayo Clinic, Rochester, MN
Lake Washington Vascular Surgeons, Bellevue and Kirkland, Washington
Wound Care Specialist, Gonda Vascular Center, Mayo Clinic, Rochester, Minnesota
Assistant Professor of Vascular Surgery, University of Michigan and Ann Arbor Veterans Association, Samuel and Jean Frankel Cardiovascular Center, Ann Arbor, Michigan
Research Fellow, Emeritus, Department of Internal Medicine and Gonda Vascular Center, Mayo Clinic, Rochester, MN
Professor of Surgery, New York University School of Medicine; Director of Aortic Center, New York University Langone Medical Center, New York, NY
Physical Medicine and Rehabilitation Specialist, Santa Monica, CA
Rane Center for Venous and Lymphatic Diseases, Jackson, Mississippi
Clinical Professor of Surgery, University of Illinois College of Medicine Chair of Surgery, Advocate Lutheran General Hospital, Niles, Illinois
Dr Regulski is a fellow faculty of the Royal College of Physicians and surgeons in Glasgow Scotland. He has been the Director of the Wound Institute for 17 years Senior partner at Ocean County foot and ankle surgical associates. He has been the principal investigator on dozens of clinical trials. He is a triple board-certified podiatrist and is on the editorial board for eight peer-reviewed journals. Dr. Regulski has published over 100 articles and peer review journals.
Dr. Garoufalis is a Past President of the Illinois Podiatric Medical Association, a Past President of the American Podiatric Medical Association, and is the Past President of the International Federation of Podiatrists. Dr. Garoufalis was a Senior Attending and the former Podiatric Surgery Residency Director at the Jesse Brown VA Medical Center. He was also an Attending Physician at Hines VA Medical Center. He has a private practice in Chicago and is part of the AMITA Health System. Dr. Garoufalis is Board Certified by the American Board of Podiatric Surgery and American Board of Podiatric Medicine with Added Qualification in Wound Care and Limb Preservation. He is a Founding Fellow of American Society of Podiatric Surgeons and a Fellow of American College of Podiatric Medicine. Dr. Garoufalis is a Fellow of the Faculty of Podiatric Medicine of the Royal College of Physicians and Surgeons of Glasgow. Dr. Garoufalis is also the Co-Chair of the Alliance of Wound Care Stakeholders. Dr. Garoufalis is currently the Chief Medical Officer for Advanced Oxygen Therapy, Inc. He is a noted, award winning researcher and author of many articles and, as an invited speaker, has accepted speaking engagements for educational lectures, seminars, and workshops, both nationally and internationally, on a variety of topics pertinent to wound care, limb salvage, podiatric medicine and surgery, and practice management. He is considered a Key Opinion Leader in many areas.
Dr. Windy Cole holds a bachelor’s degree in biology from the University of Cincinnati and is a graduate of the Kent State University College of Podiatric Medicine. Dr. Cole practices in Northeast Ohio where she serves as Medical Director of the Wound Care Center, University Hospitals Ahuja Medical Center and as Adjunct Professor and Director of Wound Care Research at Kent State University College of Podiatric Medicine. A dedicated wound care advocate for two decades, Dr. Cole is interested in medical education, diabetic foot care, wound care, limb salvage, and clinical research. Her passion to help others has led her to humanitarian efforts, including a medical mission to Jordan in 2018 to aid Syrian refugees. Dr. Cole has published numerous articles and is in demand as a speaker both nationally and internationally. She is a feature writer for Podiatry Management and Today’s Wound Clinic and is a contributing writer for Podiatry Today, The Foot Journal, and Lower Extremity Review.
Dr. James McGuire is the director of the Leonard S. Abrams Center for Advanced Wound Healing and a Professor Clinician Scholar in the Departments of Podiatric Medicine and Biomechanics at the Temple University School of Podiatric Medicine in Philadelphia. His undergraduate degree is from Bucknell University in Lewisburg, PA (1974), and his Physical Therapy Certificate is from the University of Pennsylvania, Philadelphia, PA. (1975) He practiced physical therapy in Philadelphia until 1977 when he entered Podiatric medical school.Dr. McGuire is a board-certified podiatrist and wound care specialist. He has more than 40 years of experience in biomechanics and wound management, has published extensively, and has participated in several research trials involving the diabetic foot and wound healing. Dr. McGuire has lectured both nationally and internationally in the areas of wound healing, diabetic foot management, off-loading, and biomechanics of the at-risk foot.
Keetha Hanlin, RN, LME, is a hybrid professional with a wealth of experience in both clinical and educational settings. With 20 years dedicated to operating room education and 24 years of clinical experience as a nurse educator, she has collaborated with leading figures in the venous and arterial industries. Since 2002, Keetha has also been the owner and operator of a medical spa. Her expertise in venous insufficiency is comprehensive, making her a valuable resource in this area. Currently, she serves as a Senior Clinical Advisor for Methapharm’s Asclera and ScleroSafe, where she continues to provide ongoing education and support.
Vikram Ravikumar is the Chief Operating Officer at Sun Scientific, where he leads the development, commercialization, and strategic planning of their patient-centric compression and wound care product solutions. With extensive experience in product development, IP management, regulatory compliance, and sales and marketing, Vikram has successfully launched dozens of products – including Aero-Wrap® and ExuCare®.
Neal Lonky MD, MPH is the founder and CEO of Histologics LLC, a medical device company that is dedicated to the diagnosis and effective treatment of tissue-based disease with a “compassionate” approach. He is Clinical Professor of Ob/Gyn at University of California, Irvine and still practices Gynecology part-time. Dr. Lonky received his BA from SUNY Buffalo, MD from SUNY Stony Brook, Internship and Residency from Harbor UCLA in Obstetrics and Gynecology, and Public Health degree in Health Policy and Management from UCLA. He is a former elected Director of the Southern California (Kaiser) Permanente Medical Group, multi-awarded Researcher, and recipient of Exceptional Contribution Alumni awards from both SUNY Stony Brook and the UCLA School of Public Health.
As the multi-patented inventor of Histologics’ core platform technology, the Kylon® medical fabric, Dr. Lonky has envisioned and Histologics accomplished the transformation of cervical/vaginal biopsy becoming a 21st century minimally invasive brush biopsy/tissue trap gentle experience vs the feared metal cutting tool biopsy of the early 20th century.; known as high quality “Compassionate Colposcopy®” (histologics.com). The award-winning Kylon® device technology has moved into the wound care field not only evidence-based for wound biopsy (histology and biofilm diagnosis), but also as a compassionate versatile wound debridement practice technology that wound care providers across the spectrum of expertise, from non-debridement trained caregivers providing “wound hygiene” to advanced wound care “surgical” providers in podiatry, nursing, and medicine will find of value. This is “Compassionate Debridement at your Fingertips®” (histologicswc.com).